Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 163 citing Lu: Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes. (0.08 sec) 

Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men …

- diabetesjournals.org
R Jiang, MB Schulze, T Li, N Rifai, MJ … - Diabetes Care, 2004 - Am Diabetes Assoc
RESULTS—We used Cox proportional hazard modeling to estimate the relative risk
(RR) of CVD. After adjustment for age, BMI, and other lifestyle risk factors,
the multivariate RR of CVD (the highest versus the lowest quartile) was ...
Cited by 111 - Related articles - BL Direct - All 5 versions

Effects of growth hormone on abnormal visceral adipose tissue accumulation and …


DP Kotler, N Muurahainen, C Grunfeld, C … - JAIDS Journal of Acquired Immune Deficiency …, 2004 - journals.lww.com
Methods: In this double-blind trial, 245 HIV-infected patients with excess VAT
were randomized to receive placebo (PL), recombinant human growth hormone
(r-hGH) at a dose of 4 mg daily (DD) or 4 mg on alternate days (AD) for 12 ...
Cited by 64 - Related articles - BL Direct - All 9 versions

Lipoprotein management in patients with cardiometabolic risk

- onlinejacc.org
JD Brunzell, M Davidson, CD Furberg, RB … - Diabetes Care, 2008 - Am Diabetes Assoc
Risk factors for type 2 diabetes and cardiovascular disease (CVD) often cluster,
including obesity (particularly central), insulin resistance, hyperglycemia,
dyslipoproteinemia, and hypertension. These conditions can also occur in ...
Cited by 64 - Related articles - All 22 versions

Including walnuts in a low-fat/modified-fat diet improves HDL cholesterol-to-total cholesterol …

- diabetesjournals.org
LC Tapsell, LJ Gillen, CS Patch, M Batterham … - Diabetes Care, 2004 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—This was a parallel randomized controlled trial
comparing three dietary advice groups each with 30% energy as fat: low fat,
modified low fat, and modified low fat inclusive of 30 g of walnuts per ...
Cited by 62 - Related articles - BL Direct - All 13 versions

Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors

- diabetesjournals.org
BV Howard, LG Best, JM Galloway, WJ Howard … - Diabetes Care, 2006 - Am Diabetes Assoc
RESULTS—In both sexes, diabetes increased the risk for CHD (hazard ratio 1.99
and 2.93 for men and women, respectively). Diabetic men and women had a 10-year
cumulative incidence of CHD of 25.9 and 19.1%, respectively, compared with ...
Cited by 62 - Related articles - BL Direct - All 6 versions

Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk …

- Free from Publisher
J Liu, C Sempos, RP Donahue, J Dorn, M … - Diabetes Care, 2005 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—We used four publicly available data sets for this
pooled post hoc analysis and confined the eligible subjects to white individuals
aged ≥30 years and free of CHD at baseline (12,660 men and 6,721 women). ...
Cited by 54 - Related articles - BL Direct - All 6 versions

[CITATION] Lipoprotein management in patients with cardiometabolic risk: consensus statement from …

- Free from Publisher
JD Brunzell, M Davidson, CD Furberg, RB … - Diabetes Care, 2008 - ncbi.nlm.nih.gov
1: Diabetes Care. 2008 Apr;31(4):811-22. Lipoprotein management in patients
with cardiometabolic risk: consensus statement from ...
Cited by 52 - Related articles - BL Direct - All 2 versions

Non–high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk …


J Liu, CT Sempos, RP Donahue, J Dorn, M … - The American journal of cardiology, 2006 - Elsevier
To determine if non–high-density lipoprotein (HDL) cholesterol is a more
useful predictor of coronary heart disease (CHD) risk than low-density
lipoprotein (LDL) cholesterol and if very-low-density lipoprotein (VLDL) ...
Cited by 49 - Related articles - All 14 versions

Reduced bone mineral density in human immunodeficiency virus-infected patients and its …

- endojournals.org
TT Brown, MD Ruppe, R Kassner, P Kumar, T … - Journal of Clinical Endocrinology & Metabolism, 2004 - Endocrine Soc
Reduced bone mineral density (BMD) and abnormalities in fat redistribution,
glucose homeostasis, and lipid metabolism are prevalent among HIV-infected
patients on highly active antiretroviral therapy (HAART). The relationship ...
Cited by 46 - Related articles - BL Direct - All 6 versions

Medical lipid-regulating therapy: current evidence, ongoing trials and future developments


M Evans, A Roberts, S Davies, A Rees - Drugs, 2004 - ingentaconnect.com
0012-6667/04/0011-1181/$34.00/0  2004 Adis Data Information BV. All rights
reserved. ... Current Evidence, Ongoing Trials and Future Developments ...
Marc Evans, 1 Aled Roberts, 2 Steve Davies 2 and Alan Rees 2
Cited by 45 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google